Skip to main content
. 2021 Jun 19;12(2):40. doi: 10.3390/jfb12020040

Table 5.

RCTs investigating the impact of electrical stimulation on chronic wound healing.

Study
Design
Type of ES/Electrode Placement Exposure
Duration
Type of Chronic Wound No. of Participants % Wound Area Reduction/% of Wounds Healed Reference
RCT HVPC /Treatment electrode placed over wound 50 min/day, 5 days/week for 6 weeks Pressure
ulcers
63 patients
Cathodal (n = 23)
Anodal-cathodal (n = 20)
Sham treatment(n = 20)
PAR 1 82.34% and
70.77% in ES
group, respectively, 40.53% in control/Wound healing not specified
[52]
RCT HVPC/Treatment electrode placed over wound 50 min/day, 5 days/week for 6 weeks Pressure
ulcers
77 patients
ES (n = 24)
Sham (n = 28)
US 1 (n = 25)
PAR 76.19% in ES group 48.97% in control group/52% of ulcers healed in ES group, 23% healed in control [53]
RCT HVPC/Treatment electrode placed over wound 60 min/day for 20 days Pressure
ulcers
17 patients
ES (n = 8)
Sham (n = 9)
Wound PAR not specified, higher in ES than control group/38% of ES wound healed vs. 22% in sham group (p > 0.05) [54]
RCT HVPC/Treatment electrode placed over wound 45–120 min daily for 5 weeks (45 min for sham treatment) Pressure
ulcers
60 patients
ES (n = 45)
Sham (n = 15)
After 60 and 120 min exposure PAR 91% in ES group vs. 25% in sham group/Wound healing not recorded [55]
RCT HVPC/Treatment electrode placed over wound 45 min/day,
five days/week for average 7.4 weeks
Pressure
ulcers
16 patients
ES (n = 9)
Sham (n = 7)
100% wound area reduction in treatment group, 28.9% increase in wound area in control group/Complete healing in ES group [56]
RCT Biphasic current/Treatment electrode places across wound on intact skin 30 min/day, 3 days/week,
for 4 weeks
Mixed ulcers
(diabetic and vascular)
17 patients
Diabetic (n = 8) Non-diabetic
(n = 9)
PAR 70% in diabetic group, 38.4% in non-
diabetic group/Wound healing not specified
[57]
RCT HVPC/Treatment electrode placed over wound 45 min/day,
3 days/week
for 4 weeks
Mixed ulcers
(diabetic and
venous)
27 patients
ES (n = 14)
Sham (n = 13)
Wound PAR 44.3% in ES group and 16.6% in control group/Wound healing not specified [58]
RCT PC (using bodyflow device)/Treatment electrodes placed above and below the wound site 20 min/day, 4 days/week for 8 weeks Venous ulcers 23 patients
ES (n = 14)
Sham (n = 9)
PAR 32.67% in ES,
Sham ES 23.15%/Wound healing not recorded
[59]
RCT Biphasic PC/Treatment electrodes placed over intact skin proximal to the wound site 30 min of exposure Diabetic footulcers 80 patients
Asymmetrical
PC (n = 21),
Symmetrical
PC (n = 20),
Low stimulation current (n = 19)
Sham (n = 20)
Healing rate per week:
27% in asymmetrical PC, 16% in symmetrical PC, ~9.7% in control group/Wound healing not recorded
[60]
RCT AC /Not specified 20 min twice daily for 12 weeks Diabetic footulcers 51 patients
ES (n = 24)
Placebo (n = 27)
PAR 61% in ES group, 41% in placebo group/42% of ES exposed ulcers healed vs. 15% in placebo group [61]
RCT HVPC/Treatment electrodes embedded in stockings placed around the wound 8 h nightly for 12 weeks Diabetic footulcers 40 patients
ES (n = 20)
Sham (n = 20)
PAR 86% in ES group, 71% in sham group/65% of ES wounds healed vs. 35% of wounds in sham group [62]
RCT HVPC/Treatment electrodes placed on opposite edges of the wound site 50 min/day,
5 day/week for 8 weeks
Pressure
ulcers
61 patients
Anodal HVPC (n = 20)
Cathodal HVPC (n = 21)
Sham (n = 20)
PAR 64.1% in anodal HVPC group, 74.06% in cathodal HVPC group, 41.42% in sham group/Complete wound healed not recorded [63]

HVPC: High voltage pulsed current; AC: Alternating current; 1 PAR: Percentage area reduction; US: Ultrasound.